share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  06/14 16:33
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion Pharmaceuticals公司的高管Secora Michael計劃於2024年06月14日以每股總市值爲139,081.62美元的價格賣出15,000股A類股票,該股票是通過股票期權行權於2023年06月13日獲得,最初由發行人發行。該交易是在2023年03月01日採取的預定交易活動的一部分。此次出售是在過去三個月內進行的一系列交易之後,該高管總共出售了63,124股。
Recursion Pharmaceuticals公司的高管Secora Michael計劃於2024年06月14日以每股總市值爲139,081.62美元的價格賣出15,000股A類股票,該股票是通過股票期權行權於2023年06月13日獲得,最初由發行人發行。該交易是在2023年03月01日採取的預定交易活動的一部分。此次出售是在過去三個月內進行的一系列交易之後,該高管總共出售了63,124股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息